REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Mitra Abadi Nutraceutical (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pt Mitra Abadi Nutraceutical Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Mitra Abadi Nutraceutical is an enterprise based in Indonesia. Its main office is in West Jakarta. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on February 18, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 12.79% in 2024. During that time, Pt Mitra Abadi Nutraceutical’s total assets grew by 14.25%.

Headquarters
Kota Jakarta Barat Kedoya Selatan Kebon Jeruk Dki Jakarta
West Jakarta; Jakarta; Postal Code: 11520

Contact Details: Purchase the Pt Mitra Abadi Nutraceutical report to view the information.

Website: http://www.pt-man.co.id

Basic Information
Registered Capital:
Purchase the Pt Mitra Abadi Nutraceutical report to view the information.
Financial Auditors:
Purchase the Pt Mitra Abadi Nutraceutical report to view the information.
Incorporation Date:
February 18, 2014
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Mitra Abadi Nutraceutical report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
12.79%
Total Operating Revenue
12.79%
Total Assets
14.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?